Bhattamisra SK - Search Results

1

Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications.

Bhattamisra SK, Koh HM, Lim SY, Choudhury H, Pandey M. Bhattamisra SK, et al. Biomolecules. 2021 Feb 20;11(2):323. doi: 10.3390/biom11020323. Biomolecules. 2021. PMID: 33672590 Free PMC article. Review.

2

Perspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal Chemotherapy.

Pandey M, Choudhury H, Yeun OC, Yin HM, Lynn TW, Tine CLY, Wi NS, Yen KCC, Phing CS, Kesharwani P, Bhattamisra SK, Gorain B. Pandey M, et al. Among authors: bhattamisra sk. Curr Pharm Biotechnol. 2018;19(4):276-292. doi: 10.2174/1389201019666180605125234. Curr Pharm Biotechnol. 2018. PMID: 29874994 Review.

3

Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention.

Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, Ling Lim GP, Rong Tay NW, Annan NC, Bhattamisra SK, Candasamy M. Tan SY, et al. Among authors: bhattamisra sk. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):364-372. doi: 10.1016/j.dsx.2018.10.008. Epub 2018 Oct 10. Diabetes Metab Syndr. 2019. PMID: 30641727 Review.

4

Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update.

Bhattamisra SK, Siang TC, Rong CY, Annan NC, Sean EHY, Xi LW, Lyn OS, Shan LH, Choudhury H, Pandey M, Gorain B. Bhattamisra SK, et al. Curr Diabetes Rev. 2019;15(5):382-394. doi: 10.2174/1573399815666190115145702. Curr Diabetes Rev. 2019. PMID: 30648511 Review.

5

Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.

Gorain B, Choudhury H, Yee GS, Bhattamisra SK. Gorain B, et al. Among authors: bhattamisra sk. Curr Pharm Des. 2019;25(26):2828-2841. doi: 10.2174/1381612825666190716102037. Curr Pharm Des. 2019. PMID: 31333092 Review.

6

Effect of madecassoside and catalpol in amelioration of insulin sensitivity in pancreatic (INS-1E) β-cell line.

Elhassan SAM, Candasamy M, Ching TS, Heng YK, Bhattamisra SK. Elhassan SAM, et al. Among authors: bhattamisra sk. Nat Prod Res. 2021 Nov;35(22):4627-4631. doi: 10.1080/14786419.2019.1696794. Epub 2019 Dec 4. Nat Prod Res. 2021. PMID: 31797687

7

Multiple Biological Effects of an Iridoid Glucoside, Catalpol and Its Underlying Molecular Mechanisms.

Bhattamisra SK, Yap KH, Rao V, Choudhury H. Bhattamisra SK, et al. Biomolecules. 2019 Dec 24;10(1):32. doi: 10.3390/biom10010032. Biomolecules. 2019. PMID: 31878316 Free PMC article. Review.

8

Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.

Bhattamisra SK, Shak AT, Xi LW, Safian NH, Choudhury H, Lim WM, Shahzad N, Alhakamy NA, Anwer MK, Radhakrishnan AK, Md S. Bhattamisra SK, et al. Int J Pharm. 2020 Apr 15;579:119148. doi: 10.1016/j.ijpharm.2020.119148. Epub 2020 Feb 19. Int J Pharm. 2020. PMID: 32084576

9

3D printing for oral drug delivery: a new tool to customize drug delivery.

Pandey M, Choudhury H, Fern JLC, Kee ATK, Kou J, Jing JLJ, Her HC, Yong HS, Ming HC, Bhattamisra SK, Gorain B. Pandey M, et al. Among authors: bhattamisra sk. Drug Deliv Transl Res. 2020 Aug;10(4):986-1001. doi: 10.1007/s13346-020-00737-0. Drug Deliv Transl Res. 2020. PMID: 32207070 Review.

10

Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.

Bhattamisra SK, Shin LY, Saad HIBM, Rao V, Candasamy M, Pandey M, Choudhury H. Bhattamisra SK, et al. CNS Neurol Disord Drug Targets. 2020;19(3):174-183. doi: 10.2174/1871527319666200518102130. CNS Neurol Disord Drug Targets. 2020. PMID: 32418534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters